Craft

Amneal Pharmaceuticals

Stock Price

$8.6

2024-10-29

Market Capitalization

$2.6 B

2024-10-29

Revenue

$3 B

FY, 2025

Amneal Pharmaceuticals Summary

Company Summary

Overview
Amneal Pharmaceuticals is a company engaged in the development, manufacturing, and distribution of generic and specialty pharmaceutical products. It provides oral solids, injectables, ophthalmics, inhalation products, biosimilars, and therapies for central nervous system disorders, oncology, endocrinology, and pain management. The company supplies its products to retail pharmacies, hospitals, health systems, and government agencies.
Type
Public
Status
Active
Founded
2002
HQ
Bridgewater Township, NJ, US | view all locations
Website
https://amneal.com/
Cybersecurity rating
ESG rating
40-49 out of 100|View all ESG data
Sectors

Key People

  • Chirag Patel

    Chirag Patel, Co-Chief Executive Officer and President, Director

  • Paul Meister

    Paul Meister, Chairman

    • Chintu Patel

      Chintu Patel, Co-Chief Executive Officer, Director

      • Deb Autor

        Deb Autor, Director

        LocationsView all

        18 locations detected

        • Bridgewater Township, NJ HQ

          United States

          400 Crossing Blvd 3rd Floor

        • Branchburg, NJ

          United States

          131 Chambers Brook Rd

        • East Hanover, NJ

          United States

          1 Murray Rd

        • Glasgow, KY

          United States

          118 Beaver Trail

        • Glasgow, KY

          United States

          40 Aberdeen Dr

        • Hauppauge, NY

          United States

          75 Adams Ave

        and 12 others

        Amneal Pharmaceuticals Financials

        Summary Financials

        Revenue (Q1, 2026)
        $722.5M
        Gross profit (Q1, 2026)
        $320.1M
        Net income (Q1, 2026)
        $78.0M
        Cash (Q1, 2026)
        $197.7M
        EBIT (Q1, 2026)
        $141.8M
        Enterprise value
        $5.0B

        Footer menu